Clinical Data

arrow miss target fail attempt try
Biotech

Contineum-J&J drug fails to improve vision in phase 2 MS trial

The Johnson & Johnson-partnered asset failed to trigger any significant change in vision acuity for MS patients.
Gabrielle Masson Nov 20, 2025 5:26pm
An artists impression of influenza molecules The molecules are blue and have multicolored centers

Pfizer details phase 3 data for mRNA flu vaccine

Nov 20, 2025 11:25am
An arrow incrementally going up stairs before pointing straight up Blue background

Merck's HIV combo matches Gilead's Biktarvy in phase 3 test

Nov 19, 2025 8:10am
IBD

Vanda tackles Wegovy-driven vomiting, sparking race to ph. 3

Nov 18, 2025 10:44am
Graphic image of an arrow nailing the bullseye of a target

Roche's oral SERD hits goal in adjuvant breast cancer phase 3

Nov 18, 2025 9:16am
next step ladder climb succeed win

Nuvalent races to FDA to challenge Pfizer for lung cancer market

Nov 17, 2025 7:45am